PLODJNKPEZHODA-QFIPXVFZSA-N
C28H37F3N6O5S — CID 146217735
Data last refreshed: (MolForge compound catalog, from PubChem)
About PLODJNKPEZHODA-QFIPXVFZSA-N
PLODJNKPEZHODA-QFIPXVFZSA-N (PubChem CID 146217735) has the molecular formula C28H37F3N6O5S and a molecular weight of 626.70 g/mol. Its IUPAC name is [4-[1-[6-[(2S)-2-(2-phenylethylcarbamoyl)pyrrolidin-1-yl]-2-(trifluoromethyl)pyrimidin-4-yl]piperidin-4-yl]butanoylamino]methanesulfonic acid.
Molecular Properties
| Compound Name | PLODJNKPEZHODA-QFIPXVFZSA-N |
|---|---|
| PubChem CID | 146217735 |
| Molecular Formula | C28H37F3N6O5S |
| Molecular Weight | 626.70 g/mol |
| Exact Mass | 626.25 |
| IUPAC Name | [4-[1-[6-[(2S)-2-(2-phenylethylcarbamoyl)pyrrolidin-1-yl]-2-(trifluoromethyl)pyrimidin-4-yl]piperidin-4-yl]butanoylamino]methanesulfonic acid |
| SMILES | O=C(CCCC1CCN(c2cc(N3CCC[C@H]3C(=O)NCCc3ccccc3)nc(C(F)(F)F)n2)CC1)NCS(=O)(=O)O |
| InChI | InChI=1S/C28H37F3N6O5S/c29-28(30,31)27-34-23(36-16-12-21(13-17-36)8-4-10-25(38)33-19-43(40,41)42)18-24(35-27)37-15-5-9-22(37)26(39)32-14-11-20-6-2-1-3-7-20/h1-3,6-7,18,21-22H,4-5,8-17,19H2,(H,32,39)(H,33,38)(H,40,41,42)/t22-/m0/s1 |
| InChIKey | PLODJNKPEZHODA-QFIPXVFZSA-N |
| XLogP | 3.17 |
| TPSA | 144.83 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 626.70 |
| LogP ≤ 5 | 3.17 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Sulfonic_acid_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146217735 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.